Mazen Tolaymat

Mazen Tolaymat practices at Nazareth Endoscopy Center, LLC - HOPD in Easton, Pennsylvania.

Mazen Tolaymat's NPI, 1902291594, was assigned on April 1, 2015. Mazen Tolaymat graduated from Drexel University College of Medicine in 2015. Mazen Tolaymat holds Pennsylvania license MD477118.

Mazen Tolaymat's primary practice is Nazareth Endoscopy Center, LLC - HOPD, at 2401 Northampton St, Easton, PA 18045.

Mazen Tolaymat's primary practice is Nazareth Endoscopy Center, LLC - HOPD in Easton, Pennsylvania. Mazen Tolaymat is also affiliated with Lehigh Valley Hospital-Cedar Crest. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Mazen Tolaymat to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mazen Tolaymat practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Mazen Tolaymat's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Mazen Tolaymat is licensed in Pennsylvania.

CMS data shows 648 Medicare services from Mazen Tolaymat across 12 procedure codes in 2024, for 367 Medicare patients. Medicare paid $58,848 for them.

CMS counts 367 Medicare patients who saw Mazen Tolaymat in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mazen Tolaymat's median patient age at 62, with 59% women.

In 2024, Mazen Tolaymat wrote 553 Medicare Part D claims for 147 patients. 83% of them were for generic drugs. CMS names the drug for 417 of them, across 8 drugs with 11 or more claims each, at $24,132 in total drug cost. In 2023, CMS named 221 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Mazen Tolaymat for performance year 2024, reported through an alternative payment model (APM). Mazen Tolaymat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mazen Tolaymat as offering telehealth. CMS counts 131 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Mazen Tolaymat, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Mazen Tolaymat, published from 2019 to 2021. 2021 was the busiest year, with 2. Mazen Tolaymat's most frequent co-authors are Jean-Pierre Raufman, MD, Guofeng Xie, MD and Shien Hu, MD.

CMS Open Payments shows 120 general payments to Mazen Tolaymat from 26 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 73% of the total. Phathom Pharmaceuticals, Inc. paid the most, $1,366.

Mazen Tolaymat graduated from Drexel University College of Medicine in 2015.